The company has developed a proprietary brain stimulation device that uses high-frequency magnetic pulses for transcranial neuromodulation to treat neurodegenerative disorders such as Parkinson's disease and dementia. The technology is FDA cleared and has the same efficacy as hospital treatment, but can be used by patients directly from their homes, making it more accessible and cost-effective. Non-invasive brain stimulation is a widely-used treatment for depression, but the cost of the device and complexity of treatment application limits its use to hospitals.